APTA.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:35):

Stats
Today's Volume	4.83M
Average Volume	7.82M
Market Cap	4.21M
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.110
ATR14	£0.0340 (4.13%)

Volume Correlation

Long: 0.07 (neutral)

Short: 0.36 (neutral)

Signal:(49.629) Neutral

Aptamer Group plc Correlation

10 Most Positive Correlations
C4XD.L	0.962
MOTR.L	0.945
BRD.L	0.944
MIRI.L	0.94
MCL.L	0.939
LOOP.L	0.938
ETX.L	0.932
WSBN.L	0.932
SOHO.L	0.932
MIND.L	0.93

10 Most Negative Correlations
JPSA.L	-0.952
JGSA.L	-0.94
EDIV.L	-0.939
BILN.L	-0.938
RM.L	-0.929
FEDF.L	-0.926
HEDF.L	-0.925
XFFE.L	-0.924
GBSS.L	-0.924
SGLN.L	-0.922

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aptamer Group plc Correlation - Currency/Commodity

-0.14
( neutral )

-0.09
( neutral )

0.00
( neutral )

-0.11
( neutral )

0.00
( neutral )

0.48
( neutral )

Aptamer Group plc Financials

Annual	2022
Revenue:	£1.75M
Gross Profit:	£359 000 (20.49 %)
EPS:	£-0.110

FY	2022
Revenue:	£1.75M
Gross Profit:	£359 000 (20.49 %)
EPS:	£-0.110

FY	2022
Revenue:	£4.04M
Gross Profit:	£2.69M (66.53 %)
EPS:	£-0.0324

FY	2020
Revenue:	£854 568
Gross Profit:	£455 970 (53.36 %)
EPS:	£-0.00979

Financial Reports:

No articles found.

Aptamer Group plc

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom.